Stereotactic Radiotherapy in Combination with Immunotherapy in Treatment of Advanced Recurrent Squamous Cell Carcinoma of the Larynx

Stereotactic Radiotherapy in Combination with Immunotherapy in Treatment of Advanced Recurrent Squamous Cell Carcinoma of the Larynx

Squamous cell carcinoma (SCC) of the larynx in advanced stages is a challenging malignancy to treat with a high recurrence and death rate. An individualized approach to treatment is crucial in such patients. We present a 58-year-old male patient with SCC of the larynx in the T3N0M0 stage who was tre...

Full description

Bibliographic Details
Main Authors:	Paweł Polanowski, Aleksandra Nasiek, Aleksandra Grządziel, Agnieszka Pietruszka, Krzysztof Składowski, Katarzyna Polanowska
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Series:	Biomedicines
Subjects:	stereotactic radiotherapy immunotherapy squamous cell carcinoma head and neck cancer
Online Access:	https://www.mdpi.com/2227-9059/11/7/2067

Similar Items

Stereotactic Radiotherapy Boost in Treatment of Persistent Periocular Sebaceous Carcinoma after Surgery
by: Paweł Polanowski, et al.
Published: (2023-05-01)

Tumor volume changes after stereotactic, hypofractionated and conventional radiotherapy in paragangliomas of head and neck
by: Paweł J. Polanowski, et al.
Published: (2024-09-01)

Escalating a Biological Dose of Radiation in the Target Volume Applying Stereotactic Radiosurgery in Patients with Head and Neck Region Tumours
by: Paweł Polanowski, et al.
Published: (2022-06-01)

Stereotactic ablative radiotherapy for treating primary head and neck cancer and locoregional recurrence: A comprehensive review of the literature
by: Ciro Franzese, et al.
Published: (2024-05-01)

Abscopal Effect after Stereotactic Body Radiotherapy with Nivolumab for Lung Metastasis of Head and Neck Cancer: A Case Report
by: Masashi Endo, et al.
Published: (2023-11-01)

Stereotactic body radiotherapy takes on Lung Oligometastases: Latest breakthroughs
by: Xin Liu, et al.
Published: (2024-06-01)

Management of Chordoma and Chondrosarcoma with Fractionated Stereotactic Radiotherapy
by: Harish N. Vasudevan, et al.
Published: (2017-06-01)

Advances in Radiobiology of Stereotactic Ablative Radiotherapy
by: Bin Qiu, et al.
Published: (2020-08-01)

A phase II study of personalized ultrafractionated stereotactic adaptive radiotherapy for palliative head and neck cancer treatment (PULS-Pal): a single-arm clinical trial protocol
by: P. Travis Courtney, et al.
Published: (2024-12-01)

Stereotactic Body Radiotherapy as Primary Therapy for Head and Neck Cancer in the Elderly or Patients with Poor Performance
by: Arya eAmini, et al.
Published: (2014-10-01)

Stereotactic ablative radiotherapy for primary renal cell carcinoma
by: Daniel X. Yang, et al.
Published: (2024-01-01)

Volumetric reduction of brain metastases after stereotactic radiotherapy: Prognostic factors and effect on local control
by: Naoyuki Kanayama, et al.
Published: (2022-12-01)

Effective salvage of recurrent craniopharyngioma with fractionated stereotactic radiotherapy
by: Laura Burgess, et al.
Published: (2020-10-01)

A framework for exactrac dynamic commissioning for stereotactic radiosurgery and stereotactic ablative radiotherapy
by: Ben Perrett, et al.
Published: (2022-01-01)

Stereotactic radiotherapy: An educational narrative review
by: Agha Muhammad Hammad Khan, et al.
Published: (2024-03-01)

Stereotactic body radiotherapy plus cetuximab for previously irradiated un-resectable head and neck cancer
by: Tai-Lin Huang, et al.
Published: (2022-10-01)

Stereotactic Radiotherapy in Uveal Melanoma
by: Ela Delikgöz Soykut, et al.
Published: (2014-09-01)

Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma
by: Barney Brandon M, et al.
Published: (2012-05-01)

Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
by: Jongmoo Park, et al.
Published: (2019-09-01)

Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5
by: Robert Olson, et al.
Published: (2018-10-01)

Histopathological Examination of an Explanted Heart in a Long-Term Responder to Cardiac Stereotactic Body Radiotherapy (STereotactic Arrhythmia Radioablation)
by: Marcin Miszczyk, et al.
Published: (2022-07-01)

STEREOTACTIC RADIOTHERAPY AND RADIOSURGERY IN THE TREATMENT OF PATIENTS WITH BRAIN PILOID ASTROCYTOMAS OF DEEP LOCATION
by: Yu. Yu. Trunin, et al.
Published: (2015-04-01)

Treatment of metastatic breast cancer by stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS)
by: Xiaomin Li, et al.
Published: (2024-12-01)

Effect of stomach size on organs at risk in pancreatic stereotactic body radiotherapy
by: Osamu Tanaka, et al.
Published: (2022-07-01)

Incorporating Stereotactic Ablative Radiotherapy into the Multidisciplinary Management of Renal Cell Carcinoma
by: Rohit K. Raj, et al.
Published: (2023-12-01)

Factors influencing local control after MR-guided stereotactic body radiotherapy (MRgSBRT) for adrenal metastases
by: Gamze Ugurluer, et al.
Published: (2024-05-01)

Evolution of Stereotactic Ablative Radiotherapy in Lung Cancer and Birmingham’s (UK) Experience
by: Sundus Yahya, et al.
Published: (2018-07-01)

Pain Relief after Stereotactic Radiotherapy of Pancreatic Adenocarcinoma: An Updated Systematic Review
by: Milly Buwenge, et al.
Published: (2022-04-01)

Ultra-Hypofractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer: Clinical Outcomes, Patterns of Recurrence, Feasibility of Definitive Salvage Treatment, and Competing Oncological Risk
by: Marcin Miszczyk, et al.
Published: (2022-09-01)

Stereotactic radiotherapy in the treatment of lung cancer - current prospective
by: Poparić-Banđur Bojana, et al.
Published: (2024-01-01)

Stereotactic radiotherapy for brain metastases: predictive factors of radionecrosis
by: Benoît Calderon, et al.
Published: (2023-07-01)

Stereotactic Radiotherapy for Parasagittal and Parafalcine Meningiomas: Patient Selection and Special Considerations
by: Pinzi V, et al.
Published: (2019-11-01)

Influencing Factors on Radiotherapy Outcome in Stage I-II Glottic Larynx Cancer—A Multicenter Study
by: Olgun Elicin, et al.
Published: (2019-09-01)

Stereotactic radiotherapy for ventricular tachycardia: A study protocol [version 2; peer review: 2 approved]
by: Yurika Shindo, et al.
Published: (2023-12-01)

Untoward global effects of current guideline formulation of stereotactic radiotherapy for symptomatic brain metastases by international medical societies
by: Dorien E.C.M. de Vocht, et al.
Published: (2023-09-01)

Stereotactic Body Radiotherapy for Centrally Located Non-small Cell Lung Cancer
by: Yuming WAN, et al.
Published: (2018-05-01)

Effect of stereotactic radiotherapy on immune microenvironment of lung cancer
by: Yao Xiao, et al.
Published: (2022-09-01)

Radiation Necrosis Following Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy with High Biologically Effective Doses for Large Brain Metastases
by: Leonie Johannwerner, et al.
Published: (2023-04-01)

Revolutionizing localized prostate cancer treatment: Stereotactic radiotherapy “Moroccan experience”
by: Asmâa Naim, et al.
Published: (2024-02-01)

Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters
by: Jiang Xue-song, et al.
Published: (2012-03-01)